ARDT vs. HIMS, RDNT, OPCH, GH, SHC, VCYT, BTSG, LFST, SGRY, and CON
Should you be buying Ardent Health Partners stock or one of its competitors? The main competitors of Ardent Health Partners include Hims & Hers Health (HIMS), RadNet (RDNT), Option Care Health (OPCH), Guardant Health (GH), Sotera Health (SHC), Veracyte (VCYT), BrightSpring Health Services (BTSG), LifeStance Health Group (LFST), Surgery Partners (SGRY), and Concentra Group Holdings Parent (CON). These companies are all part of the "healthcare" industry.
Ardent Health Partners vs.
Hims & Hers Health (NYSE:HIMS) and Ardent Health Partners (NYSE:ARDT) are both mid-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, earnings, media sentiment, analyst recommendations, dividends, risk, institutional ownership, valuation and community ranking.
Hims & Hers Health received 24 more outperform votes than Ardent Health Partners when rated by MarketBeat users. However, 85.00% of users gave Ardent Health Partners an outperform vote while only 39.05% of users gave Hims & Hers Health an outperform vote.
Hims & Hers Health has a net margin of 8.19% compared to Ardent Health Partners' net margin of 0.00%. Hims & Hers Health's return on equity of 10.97% beat Ardent Health Partners' return on equity.
63.5% of Hims & Hers Health shares are owned by institutional investors. 17.7% of Hims & Hers Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Hims & Hers Health presently has a consensus target price of $25.13, indicating a potential downside of 15.26%. Ardent Health Partners has a consensus target price of $22.00, indicating a potential upside of 56.75%. Given Ardent Health Partners' stronger consensus rating and higher probable upside, analysts plainly believe Ardent Health Partners is more favorable than Hims & Hers Health.
In the previous week, Hims & Hers Health had 15 more articles in the media than Ardent Health Partners. MarketBeat recorded 25 mentions for Hims & Hers Health and 10 mentions for Ardent Health Partners. Ardent Health Partners' average media sentiment score of 0.81 beat Hims & Hers Health's score of 0.54 indicating that Ardent Health Partners is being referred to more favorably in the news media.
Ardent Health Partners has higher revenue and earnings than Hims & Hers Health.
Summary
Hims & Hers Health beats Ardent Health Partners on 8 of the 15 factors compared between the two stocks.
Get Ardent Health Partners News Delivered to You Automatically
Sign up to receive the latest news and ratings for ARDT and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Ardent Health Partners Competitors List
Related Companies and Tools
This page (NYSE:ARDT) was last updated on 1/21/2025 by MarketBeat.com Staff
Free ARDT Stock Alerts